Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Interactive radiopharmaceutical facility between Yale Medical Center and Brookhaven National Laboratory. Progress report, June 1981-July 1982

Technical Report ·
DOI:https://doi.org/10.2172/6817002· OSTI ID:6817002
Progress is reported in the following research areas: (1) evaluation of /sup 14/C-labelled carboxyethyl ester 2-cardoxy methyl ester of arachidonic acid; (2) the effects of drug intervention on cardiac inflammatory response following experimental myocardial infarction using indium-111 labeled autologous leukoyctes; (3) the evaluation of /sup 97/Ru-oxine to label human platelets in autologous plasma; and (4) the specific in vitro radiolabeling of human neutrophils. (ACR)
Research Organization:
Yale Univ., New Haven, CT (USA). School of Medicine
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-76EV04078
OSTI ID:
6817002
Report Number(s):
DOE/EV/04078-T3; ON: DE82021043
Country of Publication:
United States
Language:
English